In Crawfordsville, Medicaid paid at least $3,551 in 2024 for services billed under HCPCS codes directly tied to COVID-19, according to records from the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid is a state-managed public health insurance program funded through both federal and state dollars. The program covers people with low incomes, seniors, children, and individuals with disabilities, making it one of the largest components of the U.S. health care system.
Since Medicaid is funded by taxpayers, shifts in local service billing highlight how public health funds are distributed within the community.
This report classifies services as COVID-19–related by identifying HCPCS codes that are labeled or designated as “COVID-19” or “coronavirus” within billing details or reference materials. Therefore, the amounts cited reflect only those services explicitly marked as COVID-related; services indirectly connected to the pandemic but not coded as such are excluded.
For context, Hammond documented the highest Medicaid payments for COVID-19 services in Indiana in 2024, with $443,500 in virus-related claims.
There were two providers in Crawfordsville that filed Medicaid claims for COVID-19–specific services in 2024. Among these, Immunoassay was the most billed code, totaling $2,226.
On average, each provider in Crawfordsville received $1,775 in Medicaid payments for COVID-19–specific services, below the statewide average of $17,610.
During the main pandemic years, spending on COVID-19 services contributed a notable share of the overall increase in Medicaid payments in Crawfordsville.
Between 2020 and 2024, total Medicaid payments across non–COVID-19 categories grew by $3,275,860—a 109.1% increase.
During the two-year period preceding the pandemic, annual average Medicaid payments in Crawfordsville amounted to $2,252,063.
The Centers for Medicare & Medicaid Services reports that combined state and federal spending on Medicaid reached about $871.7 billion in fiscal year 2023, making up close to 18% of all national health care spending, and rising from about $613.5 billion in 2019, the year before the COVID-19 pandemic.
This represents a nearly 40% increase over several years, largely attributed to broader enrollment and greater service use during and following the pandemic.
Recent federal budget policy passed under the Trump administration has featured notable plans to limit federal Medicaid allocations and revise program structure. For instance, the “One Big Beautiful Bill Act,” enacted in 2025, is expected to cut federal support for Medicaid by more than $1 trillion over 10 years and introduce new policies—such as work requirements and increased cost-sharing—that may reduce coverage for some participants. These adjustments would increase financial responsibility for states and slow the growth of federal spending on Medicaid as the program continues to assist tens of millions of Americans.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $3,551 | -98.2% | $6,282,903 |
| 2023 | $193,208 | -39% | $15,519,282 |
| 2022 | $316,905 | 76.2% | $12,709,231 |
| 2021 | $179,809 | 107.4% | $8,157,138 |
| 2020 | $86,702 | N/A | $3,090,195 |
| 2019 | $0 | N/A | $3,019,899 |
| 2018 | $0 | N/A | $1,484,228 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $2,226 | 119 |
| 87635 | COVID Specific | $1,325 | 36 |
Note: Includes only HCPCS codes specified for COVID-19 services; total amounts do not include all spending linked to the pandemic.
Data for this article was sourced from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original source material can be viewed here.



